LOGIN
AAOS 2024: Methylprednisolone Taper + Multimodal Pain Management for Total Shoulder Arthroplasty
February 2024
AAOS 2024: Methylprednisolone Taper + Multimodal Pain Management for Total Shoulder Arthroplasty
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Methylprednisolone taper is an effective addition to multimodal pain regimens after total shoulder arthroplasty: results of a randomized controlled trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
67 patients undergoing total shoulder arthroplasty were randomized to receive either a tapering course of methylprednisolone (n=35) or a control group (n=32). Outcomes of interest included pain on a Visual Analog Scale (VAS), cumulative oxycodone tablet consumption, opioid-related side effects, quality of life, shoulder function by Single Assessment Numeric Evaluation (SANE), American Shoulder and...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.